{{Cite journal| doi = 10.1007/s12020-024-03758-8| issn = 1559-0100 (Electronic) 1355-008X (Print) 1355-008X (Linking)| volume = 85| issue = 2| pages = 660–675| last1 = Tisch| first1 = C.| last2 = Xourgia| first2 = E.| last3 = Exadaktylos| first3 = A.| last4 = Ziaka| first4 = M.| title = Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19| journal = Endocrine| date = 2024-03-07| pmid = 38448675}}